Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    12584227 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting An Open-label Trial of 48-week Peginterferon Alfa-2a (PEGASYS) to Assess the Sustained Response of Chronic Hepatitis B Patients With HBeAg Seroconversion on Nucleot(s)Ide Analogue Therapy
Condition: Chronic Hepaititis B
Intervention: Drug: Pegyinterferon-alfa-2a
2 Completed Long Term Follow-up of Pegylated-Interferon Alpha-2b
Condition: Chronic Hepatitis B
Intervention: Procedure: blood samples are taken once

Indicates status has not been verified in more than two years